InsiderTrades

Form 4 for LH Labcorp

Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-11 · accession 0001127602-24-004642 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-13 2024-02-12 LH EISENBERG GLENN A CFO, EVP F - Tax $227.45 -215 44.0K -0.5% -$48.9K
D 2024-02-13 2024-02-11 LH EISENBERG GLENN A CFO, EVP M - OptEx — +807 44.3K +2% —
D 2024-02-13 2024-02-11 LH EISENBERG GLENN A CFO, EVP M - OptEx $0.00 -807 35.7K -2% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-12 F D 215 $227.45 44,045 D — —
2 Common Common Stock 2024-02-11 M A 807 — 44,260 D — — (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
3 Derivative Restricted Stock Unit 2024-02-11 M D 807 $0.00 35,739 D — · — to — 807 Common Stock (F4) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F3) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023.